rs35445653

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138694.4(PKHD1):​c.9577G>A​(p.Val3193Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00332 in 1,614,004 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 75 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 61 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.414

Publications

8 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034235418).
BP6
Variant 6-51748039-C-T is Benign according to our data. Variant chr6-51748039-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 220094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.056 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.9577G>A p.Val3193Ile missense_variant Exon 58 of 67 ENST00000371117.8 NP_619639.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.9577G>A p.Val3193Ile missense_variant Exon 58 of 67 1 NM_138694.4 ENSP00000360158.3
PKHD1ENST00000340994.4 linkc.9577G>A p.Val3193Ile missense_variant Exon 58 of 61 5 ENSP00000341097.4

Frequencies

GnomAD3 genomes
AF:
0.0169
AC:
2573
AN:
152110
Hom.:
75
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0581
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00714
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00503
AC:
1262
AN:
250900
AF XY:
0.00364
show subpopulations
Gnomad AFR exome
AF:
0.0623
Gnomad AMR exome
AF:
0.00469
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000441
Gnomad OTH exome
AF:
0.00343
GnomAD4 exome
AF:
0.00190
AC:
2784
AN:
1461776
Hom.:
61
Cov.:
34
AF XY:
0.00170
AC XY:
1233
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0580
AC:
1941
AN:
33466
American (AMR)
AF:
0.00535
AC:
239
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26132
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39698
South Asian (SAS)
AF:
0.000533
AC:
46
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5764
European-Non Finnish (NFE)
AF:
0.000255
AC:
284
AN:
1111950
Other (OTH)
AF:
0.00394
AC:
238
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
196
391
587
782
978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0169
AC:
2574
AN:
152228
Hom.:
75
Cov.:
32
AF XY:
0.0166
AC XY:
1235
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0580
AC:
2407
AN:
41534
American (AMR)
AF:
0.00713
AC:
109
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68006
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
118
236
355
473
591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
779
Bravo
AF:
0.0200
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0554
AC:
244
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00591
AC:
718
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000771

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 09, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The PKHD1 c.9577G>A (p.Val3193Ile) variant involves the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a benign outcome for this variant. This variant was found in 720/121508 control chromosomes (including 12 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.0612736 (637/10396). This frequency is about 9 times the estimated maximal expected allele frequency of a pathogenic PKHD1 variant (0.0070711). As this variant exceeds allele frequency of 5% in African population, it can be regarded a common benign polymorphism found in the populations of African origin. It has also been published as a polymorphism in literature from in a ARPKD patient/normal controls (Sharp_2005). In addition, multiple clinical diagnostic laboratories have classified this variant as benign. Taken together, this variant is classified as Benign. -

Jun 23, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15698423) -

Sep 29, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive polycystic kidney disease Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 30, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKHD1 p.Val3193Ile variant was identified in 2 of 446 proband chromosomes (frequency: 0.004) from individuals with autosomal recessive polycystic kidney disease and 5 of 600 chromosomes (frequency: 0.008) from health individuals (Sharp 2005, Bergmann 2005). The variant was identified in dbSNP (rs35445653) as “other allele”, ClinVar (classified as benign by Invitae, Integrated Genetics, Prevention Genetics and Children Mercy Hospital and likely benign by Illumina) an LOVD 3.0 (observed 2x). The variant was identified in control databases in 1787 of 282,242 chromosomes (38 homozygous) at a frequency of 0.006 (Genome Aggregation Database Feb 27, 2017) increasing the likelihood this could be a low frequency benign variant. The variant was observed in the following populations: African in 1522 of 24,938 chromosomes (freq: 0.06), Latino in 165 of 35,380 chromosomes (freq: 0.005), Other in 26 of 7208 chromosomes (freq: 0.004), South Asian in 11 of 30,616 chromosomes (freq: 0.0004), European in 57 of 128,682 chromosomes (freq: 0.0004), and East Asian in 6 of 19,946 chromosomes (freq: 0.0003); it was not observed in the Ashkenazi Jewish or Finnish populations. The p.Val3193 residue is conserved in in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.036
DANN
Benign
0.17
DEOGEN2
Benign
0.083
T;.
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.0048
N
LIST_S2
Benign
0.14
T;T
MetaRNN
Benign
0.0034
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-1.4
N;N
PhyloP100
-0.41
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.14
N;N
REVEL
Benign
0.18
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.10
MVP
0.53
MPC
0.051
ClinPred
0.0050
T
GERP RS
-4.3
Varity_R
0.022
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35445653; hg19: chr6-51612837; COSMIC: COSV61874252; API